{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-002422","form_type":"8-K","ticker":null,"cik":"0000737207","company_name":"Adhera Therapeutics, Inc.","filed_at":"2024-01-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.802239+00:00","generated_at":"2026-06-06T23:36:29.717306+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Adhera Therapeutics CEO and director resign, effective Jan 12, 2024","bullets":["Trond K. Waerness resigns from Board effective January 12, 2024; no disagreement cited.","Zahed Subhan resigns as CEO and Board member effective January 12, 2024; no disagreement cited.","Both departures are not related to company operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-002422","json":"https://secwatch.observer/filing/0001493152-24-002422.json","markdown":"https://secwatch.observer/filing/0001493152-24-002422.md","text":"https://secwatch.observer/filing/0001493152-24-002422.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/737207/000149315224002422/0001493152-24-002422-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/737207/000149315224002422/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T23:36:29.717306+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4603a19f57","claim":"Zahed Subhan resigned as Chief Executive Officer at Adhera Therapeutics, Inc..","evidence_excerpt":"on January 12, 2024, the Company received notice from Zahed Subhan that he was resigning as the Company’s Chief Executive Officer and as a member of the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/737207/000149315224002422/0001493152-24-002422-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"aa885c46d5","claim":"Trond K. Waerness resigned as Director at Adhera Therapeutics, Inc..","evidence_excerpt":"he was resigning from the Company’s Board of Directors effective January 12, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/737207/000149315224002422/0001493152-24-002422-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}